BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2398618)

  • 1. Platelet noradrenaline content as an integrated measure of variations in plasma noradrenaline.
    Ueda E; Kuchii M; Hano T; Ueno Y; Jo Y; Shima H; Nishio I; Masuyama Y
    Jpn Circ J; 1990 Apr; 54(4):383-90. PubMed ID: 2398618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet catecholamine changes in patients with pheochromocytoma].
    Okutani R; Kono K; Fukuda T; Natori J; Okamoto T; Nakamura H; Ishida H
    Masui; 1990 Jul; 39(7):839-44. PubMed ID: 2214118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated platelet norepinephrine concentration in patients with pheochromocytomas.
    Feldman JM; Klatt C
    Clin Chim Acta; 1981 Dec; 117(3):279-88. PubMed ID: 7318181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood platelet adrenaline and noradrenaline levels in patients with pheochromocytoma].
    Berent H; Uchman B; Wocial B; Januszewicz W
    Pol Tyg Lek; 1987 Apr; 42(17):515-8. PubMed ID: 3615280
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines.
    Zweifler AJ; Julius S
    N Engl J Med; 1982 Apr; 306(15):890-4. PubMed ID: 7062972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of noradrenaline and dopamine in patients with essential hypertension or with pheochromocytoma.
    Yoshimura M; Ikegaki I; Fukuyama M; Nishimura M; Takahashi H
    Clin Exp Hypertens A; 1989; 11 Suppl 1():397-402. PubMed ID: 2743600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of noradrenaline infusion on platelet catecholamine levels and platelet aggregation.
    Tomlinson B; Smith CC; Ong AC; Graham BR; Betteridge DJ; Prichard BN
    J Hypertens Suppl; 1989 Dec; 7(6):S166-7. PubMed ID: 2632706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet norepinephrine and epinephrine concentration in patients with pheochromocytoma.
    Berent H; Uchman B; Wocial B; Januszewicz W
    Am J Hypertens; 1990 Aug; 3(8 Pt 1):618-21. PubMed ID: 2222953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in plasma dopamine-beta-hydroxylase and catecholamine concentrations during surgical removal of pheochromocytoma.
    Wocial B; Januszewicz W; Siedlecki I; Feltynowski T; Debiński W
    Endokrinologie; 1982 Feb; 79(1):131-9. PubMed ID: 7084126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do catecholamines influence the level of plasma leptin in patients with phaeochromocytoma?
    Wocial B; Ignatowska-Switalska H; Berent H; Dutkiewicz-Raczkowska M; Kuczyńska K; Chodakowska J; Feltynowski T; Januszewicz W; Szostek M; Cieśla W
    Br J Biomed Sci; 2002; 59(3):141-4. PubMed ID: 12371054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of catecholamine content in human platelets; clinical implications in patients with pheochromocytoma].
    Okutani R; Kono K; Fukuda T; Nakamura H; Ishida H
    Masui; 1989 Nov; 38(11):1463-8. PubMed ID: 2585715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet noradrenaline content in hypertension].
    Ueda E; Kuchii M; Masuyama Y
    Kokyu To Junkan; 1987 Nov; 35(11):1137-44. PubMed ID: 3438594
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma noradrenaline and its deaminated metabolites in essential hypertension and pheochromocytoma.
    Mizukoshi M; Hano T; Kuchii M; Nishio I; Masuyama Y
    Jpn Circ J; 1985 Sep; 49(9):1035-42. PubMed ID: 4068201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive hormones in familial pheochromocytoma with predominant norepinephrine secretion.
    Tulassay T; Verebély T; Szücs L; Rascher W; Jellinek K; Reusz G; Miltényi M; Nagy I
    Child Nephrol Urol; 1988-1989; 9(4):228-31. PubMed ID: 3076506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma adrenomedullin concentrations in patients with adrenal pheochromocytoma.
    Letizia C; De Toma G; Caliumi C; Cerci S; Massa R; Loria RD; Alo P; Marinoni EM; Diacinti D; D'Erasmo E
    Horm Metab Res; 2001 May; 33(5):290-4. PubMed ID: 11440275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.
    Kuch-Wocial A; Slubowska K; Kostrubiec M; Pasierski T; Januszewicz W; Switalska H; Wocial B; Pruszczyk P
    Clin Chim Acta; 2004 Jul; 345(1-2):43-7. PubMed ID: 15193976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bilateral adrenal pheochromocytoma. Diagnosis and follow-up using the clonidine test and measurement of plasma neuropeptide Y concentration].
    Eisenhut S; Rascher W; Lang RE
    Monatsschr Kinderheilkd; 1990 Sep; 138(9):631-4. PubMed ID: 2233767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet alpha 2- and leucocyte beta 2-adrenoceptors in phaeochromocytoma: effect of tumour removal.
    Valet P; Damase-Michel C; Chamontin B; Durand D; Chollet F; Montastruc JL
    Eur J Clin Invest; 1988 Oct; 18(5):481-5. PubMed ID: 2852594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of platelet catecholamine content for the diagnosis of pheochromocytoma with intermittent hypertension].
    Plouin PF; Chatellier G; Billaud-Mesguich E; Comoy E; Duclos JM; Ménard J
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):812-5. PubMed ID: 3116976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does plasma neuropeptide-Y immunoreactivity in patients with pheochromocytoma depend on hormonal activity of the tumor?
    Pruszczyk P; Wocial B; Ignatowska-Switalska H; Feltynowski T; Ellafi M; Januszewicz A; Lapiński M; Zukowska-Grojec Z; Januszewicz W
    Clin Chim Acta; 1995 Dec; 243(2):205-12. PubMed ID: 8747495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.